Previous slide
Next slide

Welcome to School of Pharmacy

The school provides services in drug quality control, clinical and community pharmacy, and advice on drug manufacture in industries. Members of staff in the school have been assisting the Ministry of Health and Social Welfare as well as its various agencies in various areas of pharmaceutical service policy formulation and implementation. Some members sit in various government bodies as consultants, e.g., the Tanzania Bureau of Standards (TBS), Pharmacy Council, and Tanzania Food and Drug Authority (TFDA).

About School

Background about the school

The School of Pharmacy was established in July 1974 as the Department of Pharmacy in the Faculty of Medicine with the assistance of a grant from the British Council. The first intake of 16 students had to take most of their first-year basic science courses at the main campus of the University of Dar es Salaam, together with B.Sc. General, B.Sc. Education, and B.Sc. Geology students. Fifteen of these students graduated three years later, in 1977. Most lecturers who started the course were expatriates from Britain, Kenya, and Malawi. Since then, we have been producing quality pharmacists, who are now the backbone of the healthcare system in Tanzania and neighboring countries.

The Faculty of Pharmacy was established in 1991 under the constituent College of the University of Dar es Salaam, which became the Muhimbili University College of Health Sciences (MUCHS) in 2000. In 2003, in line with the drive for MUCHS to become a full-fledged university, the Faculty of Pharmacy was accorded school status in preparation for the expansion of its functions. The school continues to exist after the establishment of a full-fledged university, Muhimbili University of Health and Allied Sciences (MUHAS).

The school provides services in drug quality control, clinical and community pharmacy, and advice on drug manufacture in industries. Members of staff in the school have been assisting the Ministry of Health and Social Welfare as well as its various agencies in various areas of pharmaceutical service policy formulation and implementation. Some members sit in various government bodies as consultants, e.g., the Tanzania Bureau of Standards (TBS), Pharmacy Council, and Tanzania Food and Drug Authority (TFDA).

Our Programmes

Undergraduate programs offered by the School
Bachelor of Pharmacy

What is the BPharm Degree program?

The Bachelor of Pharmacy Program aims to equip the graduate pharmacist with practical skills and theoretical knowledge that enable the graduate to function as an expert in pharmaceutical care and pharmaceutical sciences. Therefore, the BPharm program embraces the search, development, formulation, analysis, storage, and distribution of products for the maintenance and restoration of good health, as well as the provision of information and guidance on the proper use of medicines. Successful applicants admitted to this program are expected to attend clinical/hospital rotations and field attachments in pharmaceutical industries, regulatory authorities, medicine chain supply entities, and herbaria. They should pass both the theoretical and practical examinations and submit independent research projects that culminate in the degree award.

 Who is eligible to apply for the program?
Applicants who enter directly from school (direct entrants) must have three principal passes in the disciplines of Chemistry, Biology, and Physics/Mathematics at a minimum of a “C” grade or higher at a “A” level. Candidates with a B or above in Biology or Chemistry, in that order, will be given preference. Applicants with a D in Mathematics or Physics at the “A” level must have at least a B in Biology and/or Chemistry. Candidates with equivalent qualifications who possess an Advanced Diploma or appropriate Diploma accredited by a relevant authority and approved by the University Senate with an overall minimum performance grade of “B” or a GPA of ≥3.5, should possess O-level passes in Mathematics, Physics, Chemistry, Biology, and English.


(Masters programmes are to be listed under the specific department offering them – see below)


Attractive and market-oriented postgraduate programs offered by the School of Pharmacy include:

  1. MSc Pharmacovigilance and Pharmacoepidemiology.

2.MSc Medicinal and Pharmaceutical Chemistry.

3.MPharm Clinical Pharmacy.

4.*MSc Bioinformatics.

5.*MSc Phytopharmaceutical and Natural Medicines Sciences.

6.*MSc in Drug Regulation

7.MPharm Pharmaceutical Microbiology.

8.MSc Pharmaceutical Management.

9.MPharm Quality Assurance  and Quality Control.

10.MSc by Research (in the field of choice/interest)


(*) underway for accreditation

Our Departments
Department of Clinical Pharmacy and Pharmacology

The Department of Clinical Pharmacy and Pharmacology started as the Unit of Pharmacology and Therapeutics in 2008 at the School of Pharmacy of Muhimbili University of Health and Allied Sciences (MUHAS). The Unit was housed in the Department of Pharmacognosy in the School of Pharmacy during this period. As a result of the increased number of faculty and postgraduate students, the Unit was upgraded to a Department in 2015. This is a clinical department whereby the members of the departments and students participate in multidisciplinary ward rounds at Muhimbili National Hospital (MNH), Jakaya Kikwete Cardiac Institute (JKCI), and Ocean Road Cancer Institute. 

Teaching and Capacity Building

The department aims to provide excellence in undergraduate and postgraduate teaching in basic and clinical pharmacology, therapeutics, clinical pharmacy, and pharmacovigilance. Teaching aims at imparting graduates with skills in providing direct patient care in collaboration with other clinical care team members in the health facilities. The focus is for trained pharmacists to be able to participate in the planning and monitoring of patient therapy, including the detection and reporting of adverse events and medication errors. The competency-based curriculum for undergraduates in the department covers three years of study, i.e., second, third, and fourth year. In semesters 3 and 5, students are taught basic pharmacology. In the second year, students cover basic principles of pharmacology, and in the third year, they cover therapeutics. In the fourth year, students spend much time in the wards in which they participate in ward rounds, review files and make presentations.

List all short courses under the department

  1. Clinical Pharmacy Services
  2. Clinical Pharmacokinetics and Drug Metabolism
  3. Bioanalysis short course

The aim of the Department of Pharmaceutical Microbiology is to equip undergraduate and postgraduate pharmacy  students  with  adequate theoretical and practical knowledge in pharmaceutical microbiology.

The subject covered include but not limited to

  • Infection control 
  • Antimicrobial resistance and sensitivity testing
  • Antimicrobial stewardship
  • HIV drug resistance
  • Environmental microorganisms monitoring
  • Sterility and pyrogen testing
  • Immunology and vaccinology
  • Microbial aspects of Pharmaceutical Manufacturing  
  • Modern  molecular   biotechnology techniques   
  • Genetic engineering of medicines, cloning,  and  sequencing  
  • Hybridoma   technology
  • Bioinformatics, including Genome wide studies, microbiomes and metagenomics analyses
  • Vacciniology and biotechnology

These concepts are encapsulated in the undergraduate and postgraduate programs

List all short courses under the department

  1. Antimicrobial Stewardship For Human Health Professionals
  2. Interpretation of genotypic HIV drug resistance

The Department of Medicinal Chemistry is one among the five departments under the school of Pharmacy. This department is focusing on teaching Medicinal and Pharmaceutical Chemistry. Research activities under this department focus on drug discovery from natural and synthetic sources, quality control and assurance of Pharmaceuticals.  The department teach courses both in undergraduate and postgraduate programs.

In undergraduate programme, medicinal chemistry (PC) is taught in even semesters covering year I –III.  Topics include Basic Chemistry (Aliphatic, Aromatic and Inorganic), Advanced Chemistry (Heterocyclic Chemistry, Stereochemistry, Organic Spectroscopy), Chemotherapeutics agents (sulfonamides, antibiotics, anticancer etc), Pharmacodynamic agents (analgesics, CNS and ANS drugs), quality assurance of medical products (Regulatory affairs, QA and QC techniques). Practical sessions are also arranged based on the themes. There are two laboratories; Wet chemistry and Instrumental laboratory.

Masters provided by this department are of two years duration. Masters of Medicinal of Chemistry which is focusing on drug design and discovery from both natural and synthetic sources. Masters of quality control and quality assurance focuses on detection, responding and reporting of substandard and falsified medical products. Different analytical equipment are available for practical learning and consultancy services.

List all short courses under the department

  1. Good Manufacturing Practice
  2. Comprehensive Quality and Equipment Qualification
  3. Good Clinical Practice Oversight
  4. Analytical Method Development and Validation

Department of Pharmaceutics and Pharmacy Practices MUHAS is the biggest department in the School of Pharmacy by harboring two examinable core courses in Undergraduate which are Pharmaceutics and Pharmacy Practices.

Also, the Department is offering two postgraduate programs which are Masters of Pharmacy in Industrial Pharmacy and Masters of Science in Pharmaceutical management.

 The department have number of experts ranging from Industrial Pharmacists, Pharmacovigilance, Regulatory Affairs, Clinical pharmacokinetics, Bioequivalence studies, Human resource management, financial management, Pharmacoeconomics, Supply chain experts and Experts in Quality Assurance and Quality Control. 

The pharmaceutics course in Bpharm program is all about drug development and formulation, processes in pharmaceutical industrial pharmaceutical technology, quality assurance and control, good manufacturing practices, drug absorption and disposition, fundamental mathematical relationships blood concentration-time profiles and the spectrum of pharmacological effects (pharmacokinetics), bioequivalence and bioavailability and radio pharmaceutics. Likewise, the pharmacy practice course covers pharmaceutical calculation and compounding of various pharmaceutical and non-pharmaceutical products, good laboratory practice, and good dispensing practice, communication skills, entrepreneurship and general management, community and hospital pharmacy, Pharmacoeconomics, supply chain management, pharmacovigilance and pharmacy law and regulatory affairs. In this regard, the department holds the great potential to conduct researches in the aforementioned areas and prepare pharmaceutical and non-pharmaceutical product which meets good manufacturing and laboratory practice

List all short courses under the department

  1. Pharmacovigilance and  Vigilance for Healthcare Professionals
  2. Supply Chain Management of Healthcare Commoditiies

Pharmacognosy is the oldest medical science that involves the study of physical, chemical, biochemical and biological properties of natural drugs. The name pharmacognosy is derived from the Greek “pharmakon” = drug & “gnosis”= knowledge. It is the key subject that deals with Drug Discovery from natural products, i.e., the search for new drugs from natural sources. Thus, the subject is one of the core branches in the pharmacy curriculum and therefore found an important niche as a coveted department in the School of Pharmacy at Muhimbili University of Health and Allied Sciences (MUHAS) since its establishment in 1974. The department holds a prestigious reputation as a crucial field, given that natural products continue to serve as vital sources of drugs or lead compounds in the prophylaxis and treatment of diseases. For instance, around 50% of pharmaceuticals are derived from molecules first identified or isolated from natural products, including herbs/plants, animals, microorganisms, marine organisms and insects, as active ingredients. Additionally, they contribute to functional foods like nutraceuticals and probiotics, playing a significant role in preventing chronic diseases.

Developing excellent appreciation of drug discovery and development from natural sources and Phytotherapy are fundamental to the training of pharmacists. The department aims to ensure that all students are competently trained in the theory and practice of Pharmacognosy and Natural Medicine to better equip them to explore the folkloric use of phytomedicines and other natural medicines. In the future, the department aims to teach students appreciate Complementary and Alternative Medicine (CAM) practices.

The department has successfully graduated over 10 postgraduates and 1 PhD scholar, all of them have secured prominent positions in the pharma industry and academia. For the past 20 years, the department has published more than 100 articles in prestigious national and international journals, showcasing its commitment to high-quality research.

Our Staff Members
Our Researches and Publications

Our Services

 1.Quality Control
With the growing number of manufacturers and importers of pharmaceuticals, the quality of medicines supplied to patients can no longer be taken for granted. The school, therefore, has an important role in ensuring drug quality, a service it has been offering since 1984. This role has been strengthened with the recent acquisition of key analytical instruments, including High-Performance Liquid Chromatography, Densitomer, Ultraviolet Spectrophotometers, Fourier Transform Infrared Spectrophotometer and Near-Infrared Spectrophotometer. The school has been able to attract consultancies in quality assurance from USAID and Management Sciences for Health.
2. Pharmaceutical Manufacturing
In order to cater for the needs of the pharmaceutical industry, the school is obliged to have a functional drug manufacturing unit in order to train industrial pharmacists to assist local industries in improving the quality of pharmaceutical products. Commensurate with this objective, the school has managed to acquire a modern Research and Development Unit for solid dosage forms. This unit is not only used for training undergraduate and postgraduate students but has also attracted consultancies in new antiretroviral drug combination formulations. Likewise, the students seeking to acquire these new skills come from as far as Kenya, Rwanda, Uganda, Nigeria, and the DRC Congo.
3. Clinical and Community Pharmaceutical Services
In hospital settings, the pharmacist is an important team member and is expected not only to provide pharmaceuticals but also to give advice on their use. This latter aspect is not well developed in this country, despite the obvious need. Such services as adverse drug reactions, monitoring, and therapeutic drug monitoring are, to a large extent, lacking. The school, therefore, plans to establish a custom-built hospital pharmacy outlet and a therapeutic drug monitoring unit. The growing number of hospital and clinical pharmacy graduates (3 so far and very soon to be 5) the school produces will act as ambassadors in advocating the need for these services.
4. Continuing Education
Technological advancement in the field of pharmacy is so rapid that there is a constant need to bring practicing pharmacists up to date. The school, therefore, plans to continue offering continuing education programs for pharmacists in the field to keep them abreast of recent developments in pharmaceutical services and new products for the management of diseases such as HIV and AIDS, malaria, and TB. Continuing education will also update trainees on product innovation and enable them to render appropriate services to the public.

5. Consultancies
Areas in which the school has offered consultancy services include: part-time teaching to other universities; short-listing of candidates for recruitment of human resources in medicine quality assurance; rational use of medicines; medicine pricing; new medicinal product development; and medicine quality assurance.

Head of Departments

Department of Clinical Pharmacy and Pharmacology

Dr. Ritah Francis Mutagonda-Head

Department of Pharmaceutical Microbiology

Dr. Liberata Alexander Mwita - Head

Department of Medicinal chemistry

Dr. Vicky manyanga - Head

Department of Pharmaceutics and Pharmacy practice

Dr. Betty Allen Maganda - Head

Department of Pharmacognosy

Dr. Rogers Mwakalukwa - Head

Our Staff Members
NameDepartment/UnitRoleCVArea of ExpertiseGrants and AwardsOCRID-link
Ms. Rose G. TembaAdministratorRose G. Temba is a Human Resource Officer in the School of Pharmacy;
· Has a background in Records Management obtained from Tanzania Public Service College and Bachelor degree in Human Resources Management and Master’s Degree in Human Resources Management with Information Technology obtained from the Tanzania Institute of Accountancy and has obtained Proficiency of Human Resources Management at Tanzania Public Service College.
Ms. Grace Hezron NteminyandaDean's Secretary. Grace Hezron Nteminyanda is a Personal Secretary in the School of Pharmacy;
. Has a background of Diploma in Personal Secretarial Duties obtained from Tanzania Public Service College (TPSC) in 2014 and continued taking the Bachelor in Human Resource Management from Institute of Social Work (ISW) from 2021/2022 academic Year up to date.
Ms. Vailet Yohana HoseaOffice AssistantOffice Assistant in the School of Pharmacy
Dr. Ritah Francis MutagondaClinical Pharmacy and PharmacologySenior LecturerDr. Mutagonda is a senior lecturer at the Department of Clinical Pharmacy and Pharmacology at Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania. She completed her Bachelor of Pharmacy Degree at MUHAS in 2007. She holds a PhD in Clinical Pharmacology since 2019 and has a Master’s degree in Pharmacology and Therapeutics from MUHAS which was supported through the Swedish International Development Cooperation Agency funding. She is a mentor and a research supervisor to postgraduate and undergraduate students and has co-authored several papers in peer reviewed journals. She has collaborated with the National AIDS Control Programme and Tanzania Medicine and Medical Devices authority towards improvement of pharmacy services in the country. Currently, she is the country’s lead investigator for a malaria chemoprophylaxis in children living with sickle cell disease.-Malaria in pregnancy
-Malaria in Sickle cell disease children
-HIV treatment in pediatrics
-Hydroxyurea use in sickle cell disease patients
-Pharmacogenetics studies
-Pharmacovigilance studies

1. Grant: U01 HL 156853
Funding period: 15th May 2021 – 30th April 2026
Title: Sickle Pan-African Research Consortium (SPARCO)-Tanzania
Role: Study Lead – Malaria chemoprophylaxis in sickle cell disease patients

2. Grant: MUHAS-SIDA seed grant for Junior Faculty
Funder: SIDA
Funding period: February 2022 – August 2022
Title: Prevalence and determinants of adverse drug reactions among HIV positive patients on antiretroviral therapy in Tanzania.
Role: Co-Principal investigator

3. Grant: MUHAS-SIDA seed grant for Junior Faculty
Funder: SIDA
Funding period: February 2021 – August 2021
Title: Uptake of Viral Load Testing and the Role of Pharmacy Refill Adherence to Predict Antiretroviral Therapy Outcome among Adolescents and Adults in Tanzania.
Role: Co-Principal investigator

4. Grant: MUHAS-SIDA seed grant for Junior Faculty
Funder: SIDA
Funding period: February 2020 – February 2021
Title: Effectiveness, Safety and Acceptability of Dolutegravir based antiretroviral regimens among HIV infected Children and Adolescents in Tanzania.
Role: Principal investigator

5. Grant: Sickle Pan-African Research Consortium (SPARCO) Tanzania research award
Study period: 1st June 2020 – 30th May 2021.
Title: Streptococcal pneumoniae carriage and antibiotic susceptibility profile among Children with Sickle Cell Disease who are using pneumococcal prophylaxis in Tanzania.
Role: Principal investigator
Professor Appolinary KamuhabwaClinical Pharmacy and PharmacologyProfessorHe completed his first degree in Pharmacy at the University of Dar es Salaam and graduated in 1994. Afterwards he pursued Masters, PhD and Postdoctoral fellowship in Pharmacology at the Catholic University of Leuven in Belgium. In 2001 he joined Muhimbili University of Health and Allied Sciences as a Lecturer, and I attained a rank of Professor in 2016.-Malaria in pregnancy
-Cardiovascular disease in particular hypertension and rheumatic heart disease
Meeting the Needs for Public Health and Workforce Training for Disadvantaged Populations: Collaboration between Muhimbili University of Health and Allied Sciences, Tanzania and Tufts University, USA. This was a planning grant sponsored by USAID through the American Council on Education and Higher Education for Development. The planning activities started in June 2009 and ended in November 2009. The planning proposal was developed and submitted to USAID in November 2009 for possible funding.
Malaria and HIV infections in pregnancy: drug interactions, effectiveness and impact of the national malaria prevention and treatment interventions on maternal and child health. This is a Sida grant-supported project which started in July 2009.
Evaluation of implementation of co-trimoxazole prophylaxis among HIV exposed children in Dar es Salaam. This is a Sida/MUHAS grant supported project. The project started in September 2013.
Strengthening capacity for development of interventions for control and elimination of malaria and neglected tropical diseases as an integral part of global efforts for sustainable development in Tanzania. This is a 5-years Sida- grant supported project which starts in July 2015 and will end in June 2020.
Pharmacovigilance of Drugs Used for Mass Administration for Neglected Tropical Diseases in Tanzania. This is EDCPT/MUHAS grant supported project. It is a 5-yesrs project and started in 2018.
Strengthening Clinical Pharmacy Practice in Tanzania. This is a one-year (April 2021 to April 2022) project between MUHAS in collaboration with Christian Social Services Commission in Tanzania. It is designed to train in-service pharmacists for provision of clinical pharmacy services in the National, Zonal and Regional Referral Hospitals in Tanzania.
Trustworthy Artificial Intelligence for Personal Risk Assessment in Chronic Heath Failure (June 2023 to June 2026). Funded by European Union.
Preventing Rheumatic Injury Biomarker Alliance (June 2023 to June 2025). Funded by Leducq Foundation, United States of America.

Facilitator in training of health care workers on drug management in the treatment and care of HIV/AIDS: National AIDS Control Program – Tanzanian Mainland and Zanzibar; from 2005 – to date
Training of Medical Stores Department Personnel on HIV Pharmaceutical Management – Contract No MSD/003/C-SERV/02/2006/07
Assessment of Pharmaceutical Management at Antiretroviral Providing Sites in Dar es Salaam and Coast Regions – Contracted by Management Science for Health – Washington (2007 - 2008) – Contract No. RPM PLUS: HRN-A-00-00-00016-00
Trainer of health care workers in Pharmaceutical Management of HIV/AIDS in Tanzania: Organized by Management Science for Health, World Health Organization (WHO) and Tanzanian National AIDS Control Program (NACP) – 2005 – to date
Provision of training services for antiretroviral therapy commodities supply chain management. Medical Stores Department; Contract No. MSD/003/C-Serv/241/2007/08.
Chairperson – Training and Capacity Building Technical Working Group. World Bank-supported East Africa Public Health Laboratory Networking Project: September 2010 – to March 2020

Professor Omary Mashiku MinziClinical Pharmacy and PharmacologyProfessorProfessor Minzi is International Renowned Researcher in Malaria and Neglected Tropical diseases (NTD) with special focus on drug safety and efficacy, Pharmacokinetics and Pharmacogenetics, he has a f PhD in Clinical Pharmacology, Sandwich -Karolinska Sweden- University of Dar Es Salaam 2000-2005, and graduated with Msc in Medical and Pharmaceutical Researches, Vrije University of Brussels, Belgium in 1993-1995
He is an MPharm degree holder from Pyatigorsk Pharmaceutical Institute, Soviet Union 1984-1989. At MUHAS, he is the founder for establishment of the Clinical Pharmacy and Pharmacology department at MUHAS and First Head of that Department, at the University. He has trained a bunch of Pharmacists in the country who are serving in various areas within the country, Africa and beyond. Similarly, about 90% of the members of academia at the School of Pharmacy at MUHAS are his products.
In Tanzania Professor Minzi:
Presides the Vigilance Technical Advisory Committee-TMDA,
He is Member of Tanzania Immunization, Technical Advisory Group (TITAG) -Ministry of Health
Chairperson The National Malarial Working Task group
Dean founder of The School of Pharmacy at St John University of Tanzania (SJUT)
Professor Minzi has done a number of research activities on Efficacy and safety of antimalarial drugs, anti-HIV and Neglected diseases.
He received training on Clinical Pharmacokinetics, Bioanalytics and Therapeutic drug monitoring at Karolinska Institute and has done a significant number of research activities on Pharmacovigilance and Bioanalytical method development and applications
He serves as Clinical Pharmacy consultant for Referral Hospitals in Tanzania.
Other Activities areas are:
Drug utilization and Rational Use of Medicines Research
Facilitator and Trainer short courses: Clinical Pharmacy, Pharmacovigilance and applied Pharmacokinetics
1. Sida malaria and NTD 2024-2029 SEK 9 Million
2. EDCTP-Strengthening Pharmacovigilance structure in East Africa 2018-2021
3. Sida Malaria and NTD Subprogram 2015 -2020 SEK 13 Million
4. Sida Malaria 2011-2015-2015 -2020 SEK 9 Million
5. Rapid funding Envelope (HIV curriculum for pharmacists on job training (Tshs 108,000, 000 Million)
Dr. Alphonce Ignace MarealleClinical Pharmacy and PharmacologyLecturerDr. Alphonce Ignace Marealle is working as a lecturer in the Department of Clinical Pharmacy and Pharmacology at Muhimbili University of Health and Allied Sciences (MUHAS). He is an expert in pharmacology, with academic background and extensive experience in research and practical work. Holding a Ph.D. in Pharmacology, a Master's degree in Clinical Pharmacology, and a Bachelor's degree in Pharmacy, he is experienced in various areas of medical and biological sciences. He has been actively involved in both pre-clinical and clinical studies, supervising numerous research projects and mentoring undergraduate and postgraduate students. Dr. Marealle has made contributions to the field through publication, with over 50 articles in reputable peer-reviewed journals. With his experience, Dr. Marealle has worked as a clinical trial pharmacist, contributing to trials, including vaccine clinical trials. He also possesses expertise and skills for isolating and elucidating structures of compounds in natural products using spectroscopic techniques like NMR. Driven by his passion for bioanalysis, Dr. Marealle is currently focusing his career on advancing bioanalysis techniques like cost effective HPLC methods development and validation for medicines relevant to our setting including antiretroviral, anti-malarial and anti-TB medicines.-Clinical and Pre- clinical studies: HIV, malaria and tuberculosis
-Antimicrobial resistance
-Rational use of medicines
2023: Recipient of MUHAS-SIDA seed grant as co-investigator for a research titled; “Point prevalence survey and pattern of antimicrobial use among hospitals in Dar es salaam”.
2022: Recipient of MUHAS-SIDA seed grant as principal investigator for a research titled “Safety evaluation of crude extracts and isolation of antimycobacterial compounds from selected Tanzanian medicinal plants used in the management of HIV and AIDS-related conditions”.
2020: Recipient of grant from MRC-NIHR Trials Methodology Research Partnership Global Health Pump Priming -Liverpool University (Co-investigator) for research titled; “Challenges in implementing vaccine clinical trial methodologies in low-income countries”.
2019: Recipient of DAAD scholarship for 7 weeks hands on training at the University of Botswana to gain skills and knowledge on isolation of peripheral blood mononuclear cells (PBMCs), lymphocyte proliferation assays, antimycobacterial assays and anti-HIV assays.
2018: Recipient of DAAD scholarship for Winter School at TU Dortmund, Germany. Natural products: Chromatography, spectroscopy and biological aspects.
2017: Recipient of DAAD/BMF scholarship for PhD study titled: “Search for potential anti-HIV-1 and antimycobacterial compounds from selected Tanzanian medicinal plants”. This was a sandwich program between MUHAS and University of Botswana.
2015: Recipient of International Atomic Energy Agency (IAEA) scholarship to attend and presented two abstracts at Experimental Biology Conference in March 28th – April 1st Boston Convention & Exhibition Center, Boston, Massachusetts, USA. Abstract number C14 II 729.14 and LB276
2015: Epidemiology and Statistics Course, School Tropical Medicine and Global Health, Nagasaki University, Japan 21st July 2015 to Monday 3rd August 2015.
2014: Recipient of International Atomic Energy Agency (IAEA) scholarship for 6 weeks on-job training at HNR Cambridge, UK to quantify Nitric oxide production using GC-MS in samples collected from children with sickle cell disease.
Wigilya P. MikomangwaClinical Pharmacy and PharmacologyAssistant LecturerPharmacist by training (2010/14) and holder of a Master of Science (MSc) in Pharmacology and Therapeutics (2017/20) from the Muhimbili University of Health and Allied Sciences (MUHAS). Holds an Implementation Science Fellowship of the Harvard T.H Chan School of Public Health, USA (2023 and 2024/25). Currently, a PhD fellow (2023/26): sandwich programme with MUHAS (Tanzania) and University of Oslo (UiO, Norway)-Drug epidemiology
-Post Authorization Safety and Efficacy Studies (PASS and PAES)
-Implementation Science and Decision Making Analysis for Health
1. Evaluation of the long-term retention to PrEP program in Tanga, Tanzania. October 2023 to October 2024. Fogarty International Center (NIH): MUHAS-Harvard T.H Chan School of Public Health. (Principal Investigator)
2. Prevalence and determinants of adverse drug reactions among HIV-positive patients on antiretroviral drugs. February 2022 to August 2023. SIDA-MUHAS; (Co-Principal Investigator)
3. Barriers to policy implementation on Isoniazid preventive therapy for children living with HIV in rural Tanzania. November 2020 to November 2021; SIDA-MUHAS. (Co-Principal Investigator)
4. Challenges in implementing vaccine clinical trial methodologies in low-income countries. August 2020 to June 2021. MRC-NIHR Trials Methodology Research Partnership Global Health Pump Priming -Liverpool University (Principal Investigator)
5. Susceptibility pattern of antibiotics reserved for use at Tertiary hospitals in Tanzania. January 2019 to December 2020. SIDA-MUHAS (Principal Investor)
Manase KilonziClinical Pharmacy and PharmacologyAssistant LecturerHolds master of science in Pharmacology and Therapeutics with Bachelor of Pharmacy degree both from Muhimbili University of Health and Allied Sciences (MUHAS) obtained in 2020 and 2014 respectively. Currently, undertaking Ph.D. in Human Genetics at the Division of Human Genetics, Faculty of Health Sciences, University of Cape Town in South Africa.-Drug safety, efficacy and effectiveness
-Antimicrobial resistance
-Public health
-Susceptibility Profile of Antibacterial Reserved use at Zonal referral, National and Special hospital in Tanzania, and the project was granted 15 million Tanzania shillings. MUHAS-Sida seed grant. Co-investigator.
Health Literacy among hypertensive patients on medication for at least one month.MUHAS-Sida seed grant. Co-investigator.
-Factors influencing underutilization of Hydroxyurea among sickle cell disease patients in Tanzania. Funded by SPARCO Tanzania. Principal investigator.
-Factors influencing utilization of praziquantel in the management of schistosomiasis in pregnant women in Tanzania. Funded by Royal Society of Tropical Medicine (RSTM). Principal investigator.
-Factors influencing access to life-saving medicines for victims of insect and animal envenomation in Mkinga District of Tanzania.Funded by Rwanda University. Principal investigator
-Repurposing The Use of Valproate, Prednisolone, Etoposide, and 6 Mercaptopurine in the Treatment of Acute Myeloid Leukaemia in Tanzania. ReVAPEMA Trial. Funded by Cure within reach. Co-investigator